Records containing: Virus-HIV
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-13National Survey on Missed Opportunities to Pre-exposure Prophylaxis for Prevention of Human Immunodeficiency Virus-infection.
-
CLINICAL_TRIALS study record update · 2026-02-05Describe and Evaluate the Impact of Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75 Who Are Being Treated at Nice University Hospital.
-
CLINICAL_TRIALS study record update · 2025-08-01Becoming HIV-Exposed, Uninfected Children Born to HIV-Positive Mothers Followed at Bichat Claude Bernard Hospital
-
CLINICAL_TRIALS study record update · 2025-04-29Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men
-
CLINICAL_TRIALS study record update · 2024-09-19Life Experience of People Aged 60 and Over Living with HIV: Quantitative Sociological Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-05-10Evaluation of the Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)
-
CLINICAL_TRIALS study record update · 2022-04-11Analysis of HIV Subtype A6 Genome in Patients With Virological Failure After Switching to Doravirine (DOR)
-
CLINICAL_TRIALS study record update · 2020-10-05Prevalence of COVID-19 Infection in a Cohort of Patient Infected by the HIV and Patients Taking PrEP Pre-exposure Prophylaxis
-
CLINICAL_TRIALS study record update · 2020-05-19QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-Patient
-
CLINICAL_TRIALS study record update · 2019-08-12Asymptomatic Obstructive Coronary Artery Disease (CAD) in Suppressed HIV-infected Patients ≥ 45 Years and 2 or More CV Risk Factors. Associations With Persistent Immune Activation and Microbial Translocation